Galera Therapeutics Inc (GRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 5,466 | 5,908 | 4,209 | 4,577 | 5,176 |
| Operating Income | -5,466 | -5,908 | -4,209 | -4,577 | -5,176 |
| Interest Expense | 0 | 0 | 0 | 0 | 705 |
| Other Income | 535 | 124 | 145 | 196 | 294 |
| Pre-tax Income | -4,931 | -5,784 | -4,064 | -4,381 | -5,587 |
| Income Tax | N/A | -203 | N/A | N/A | N/A |
| Net Income Continuous | -4,931 | -5,581 | -4,064 | -4,381 | -5,587 |
| Net Income | $-4,931 | $-5,581 | $-4,064 | $-4,381 | $-5,587 |
| EPS Basic Total Ops | -0.09 | -0.10 | -0.07 | -0.08 | -0.02 |
| EPS Basic Continuous Ops | -0.09 | -0.10 | -0.07 | -0.08 | -0.01 |
| EPS Diluted Total Ops | -0.09 | -0.10 | -0.07 | -0.08 | -0.02 |
| EPS Diluted Continuous Ops | -0.09 | -0.10 | -0.07 | -0.08 | -0.01 |
| EPS Diluted Before Non-Recurring Items | -0.08 | -0.06 | -0.07 | -0.08 | N/A |
| EBITDA(a) | $-5,466 | $-5,903 | $-4,203 | $-4,568 | $-4,961 |